One of the most common mistakes made in both conventional and functional medicine is evaluating iron in isolation. Ferritin, serum iron, transferrin saturation, and hemoglobin are often interpreted as though they exist independently of the broader mineral network. In reality, iron metabolism is inseparable from copper status, profoundly influenced by manganese, and heavily regulated by thyroid hormones, inflammation, and cellular energy production.
This interconnected system becomes particularly apparent when reviewing Hair Tissue Mineral Analysis (HTMA) alongside blood chemistry. Patterns that initially appear contradictory—such as elevated ferritin with symptoms of iron deficiency, low ferritin despite adequate dietary iron intake, or high tissue iron with low serum iron—often begin to make sense when copper and manganese are brought into the discussion.
The purpose of this article is to explore the physiology of iron, copper, and manganese as an integrated network rather than as individual nutrients. Understanding how these minerals interact can provide valuable insight into chronic fatigue, hypothyroidism, inflammation, anemia, neurodegeneration, and many of the paradoxical laboratory findings encountered in clinical practice.
Iron: More Than an Oxygen Carrier
Iron’s most recognized role is oxygen transport through hemoglobin and myoglobin. Approximately 65-70% of the body’s iron is incorporated into hemoglobin, where it facilitates oxygen delivery from the lungs to peripheral tissues.
However, iron’s functions extend far beyond red blood cell production.
Iron serves as a critical component of:
- Cytochrome enzymes within the mitochondrial electron transport chain
- Catalase and peroxidase antioxidant enzymes
- DNA synthesis enzymes
- Neurotransmitter production pathways
- Immune cell proliferation
- Thyroid hormone metabolism
Within mitochondria, iron-sulfur clusters are required for electron transport and ATP generation. Consequently, iron deficiency frequently presents with fatigue long before anemia develops.
The body tightly regulates iron because free iron is inherently dangerous. Through the Fenton reaction, unbound ferrous iron (Fe²⁺) reacts with hydrogen peroxide to generate hydroxyl radicals, among the most damaging reactive oxygen species in biology.
As a result, nearly all iron in circulation is bound to proteins.
Three major proteins regulate systemic iron metabolism:
Transferrin
Transferrin functions as the primary iron transport protein. It binds ferric iron (Fe³⁺) and safely delivers it to tissues.
When iron availability decreases, the liver typically increases transferrin production in an attempt to capture and transport more iron.
This is why iron deficiency commonly presents with:
- Elevated transferrin
- Elevated TIBC
- Low transferrin saturation
Ferritin
Ferritin serves as intracellular iron storage.
While ferritin is often considered a marker of iron reserves, it is also an acute-phase reactant. Inflammatory cytokines can elevate ferritin regardless of actual iron stores.
Thus, elevated ferritin does not necessarily indicate iron sufficiency.
Hepcidin
Hepcidin is arguably the master regulator of iron metabolism.
Produced primarily by the liver, hepcidin controls iron absorption and recycling through its interaction with ferroportin, the body’s primary iron export protein.
When hepcidin rises:
- Intestinal iron absorption decreases
- Macrophages retain iron
- Hepatic iron release decreases
- Serum iron falls
When hepcidin falls:
- Iron absorption increases
- Stored iron is released
Inflammation, infection, obesity, elevated IL-6, and chronic disease all stimulate hepcidin production.
This mechanism explains the common pattern of:
- Low serum iron
- Low transferrin saturation
- High ferritin
often seen in chronic inflammatory conditions.
Copper: The Mineral That Makes Iron Work
Iron receives far more attention than copper, yet iron metabolism cannot function normally without adequate bioavailable copper.
Copper can be assessed via HTMA but also via serum copper levels in the blood to get an adequate read of exactly where copper is being distributed in the body. HTMA gives an idea of storage copper while serum copper gives an idea of how copper is currently being utilized in circulation. And, if you get a serum copper, plasma zinc and ceruloplasmin, you can calculate free vs bound copper which arguably is even more valuable for determining whether copper could be causing damage in the blood. The more unbound copper (>10%), the more likely that someone’s symptoms could be related to copper toxicity.
Copper-dependent enzymes are responsible for several crucial steps in iron transport and utilization.
The most important of these is ceruloplasmin.
Ceruloplasmin: The Bridge Between Copper and Iron
Ceruloplasmin is a copper-containing ferroxidase synthesized primarily in the liver.
Its role is to oxidize ferrous iron (Fe²⁺) into ferric iron (Fe³⁺), the form required for loading onto transferrin.
Without sufficient ceruloplasmin activity:
- Iron becomes trapped within tissues
- Iron cannot be efficiently loaded onto transferrin
- Serum iron falls
- Cellular iron accumulation increases
This creates one of the most misunderstood laboratory patterns in clinical practice.
A patient may demonstrate:
- Low serum iron
- Low transferrin saturation
- Symptoms consistent with iron deficiency
yet simultaneously possess excessive tissue iron accumulation.
The problem is not insufficient iron. The problem is impaired iron mobilization.
This phenomenon is frequently observed in individuals with low ceruloplasmin.
Beyond Ceruloplasmin: Other Copper-Dependent Iron Enzymes
Copper also participates through:
Hephaestin
A copper-dependent ferroxidase located within enterocytes.
Hephaestin facilitates iron export from intestinal cells into circulation.
Copper deficiency impairs dietary iron absorption despite adequate iron intake. This is another reason why someone’s gut function requires work while simultaneously working on the mineral matrix.
Cytochrome c Oxidase
Complex IV of the electron transport chain requires copper.
Consequently, copper deficiency can create symptoms virtually indistinguishable from iron deficiency:
- Fatigue
- Exercise intolerance
- Poor temperature regulation
- Brain fog
- Reduced ATP production
The Ceruloplasmin-Hypothyroid Connection
Thyroid function significantly influences copper metabolism.
T3 stimulates:
- Hepatic ceruloplasmin synthesis
- Copper incorporation into ceruloplasmin
- Iron mobilization
Hypothyroid individuals often exhibit:
- Reduced ceruloplasmin production
- Reduced iron recycling
- Functional iron deficiency
This helps explain why some patients continue to experience iron deficiency symptoms despite repeated iron supplementation.
The underlying issue may be inadequate thyroid signaling rather than inadequate iron intake.
Manganese: The Overlooked Regulator
Manganese receives far less attention than iron or copper, yet its physiological significance is substantial.
Manganese serves as a cofactor for:
- Manganese superoxide dismutase (MnSOD)
- Arginase
- Pyruvate carboxylase
- Glycosyltransferases
- Cholesterol synthesis pathways
Of these, MnSOD is particularly important.
Manganese and Mitochondrial Protection
MnSOD represents the primary antioxidant defense system within mitochondria.
During ATP production, mitochondria continuously generate superoxide radicals.
MnSOD converts these radicals into less reactive compounds, preventing oxidative damage.
Without adequate manganese:
- Mitochondrial oxidative stress rises
- ATP production declines
- Inflammatory signaling increases
- Iron-induced oxidative damage worsens
Thus manganese indirectly regulates iron toxicity.
Iron-Manganese Competition
Iron and manganese share several transport mechanisms.
Both utilize:
- DMT1 (divalent metal transporter 1)
- Similar intestinal absorption pathways
When iron stores become depleted, DMT1 expression increases.
This often leads to enhanced manganese absorption.
Clinically, iron deficiency may produce elevated tissue manganese accumulation.
Conversely, excessive iron supplementation may suppress manganese uptake.
And, this is important because individuals with a history of Lyme specifically likely already have low manganese.
This competitive relationship helps explain certain HTMA findings where manganese appears elevated in the context of iron deficiency.
The Copper-Manganese Relationship
Copper and manganese converge through oxidative stress regulation.
Copper-dependent enzymes include:
- Ceruloplasmin
- Cu/Zn superoxide dismutase
Manganese-dependent enzymes include:
- MnSOD
Together, these systems regulate redox balance throughout the body.
Deficiency in either mineral may increase oxidative stress, impair mitochondrial function, and disrupt iron handling.
Why HTMA and Blood Work Sometimes Disagree
One of the most frequent questions practitioners encounter is:
“Why does hair iron appear elevated when serum iron is low?”
The answer often lies in mineral compartmentalization.
Blood reflects circulating status.
HTMA reflects tissue deposition and elimination patterns.
The body may simultaneously demonstrate:
- Low circulating iron
- High tissue iron
- Low ceruloplasmin
- Elevated ferritin
This represents a transport problem rather than a supply problem.
Case Study 1
“The Iron Deficient Patient Who Isn’t Actually Iron Deficient”
Clinical Presentation
Sarah is a 42-year-old female presenting with:
- Severe fatigue
- Hair loss
- Cold hands and feet
- Poor exercise tolerance
- Heavy menstrual cycles
- Hypothyroid symptoms despite normal thyroid labs
She has been taking iron supplements intermittently for three years with minimal improvement.
HTMA Mineral
Result Ideal
Calcium 118 40
Magnesium 11 6
Sodium 9. 25
Potassium. 2. 10
Iron 4.2 1.8
Copper. 0.8 2.5
Zinc 18 20
Manganese 0.018. 0.04
Notable ratios:
Ca/K = 59
Na/K = 4.5
Zn/Cu = 22.5
Very slow oxidation pattern.
Blood Work
Marker. Result
Ferritin 120 ng/mL
Serum Iron 41 mcg/dL
Transferrin Saturation 10%
TIBC 410 mcg/dL
Ceruloplasmin: 15 mg/dL
Serum Copper 72 mcg/dL
TSH 3.8
Free T3 2.8
ALP 42
Plasma zinc 69
What’s Happening?
At first glance, the blood work appears consistent with iron deficiency.
Low serum iron. Low ferritin.
Low transferrin saturation.
Elevated TIBC.
Fatigue. Hair loss.
However, the HTMA tells a completely different story.
Hair iron is massively elevated while copper is significantly depressed.
This suggests iron is entering tissues but is not effectively leaving them.
Low ceruloplasmin is the key finding.
Ceruloplasmin’s ferroxidase activity converts Fe²⁺ into Fe³⁺ so transferrin can transport it. When ceruloplasmin is inadequate, iron becomes trapped inside macrophages, hepatocytes, and other tissues rather than entering circulation efficiently. (PMC)
The patient therefore experiences:
- Functional iron deficiency
- Tissue iron accumulation
- Reduced mitochondrial energy production
- Worsening oxidative stress
The elevated calcium and depressed potassium further suggest reduced thyroid effect at the cellular level.
Intervention Strategy
The worst intervention would likely be more iron.
Instead:
Phase 1
Focus on copper mobilization.
- Retinol-containing foods
- Increase zinc in the diet and consider zinc supplementation
- Support protein intake for ceruloplasmin production
- Evaluate thyroid function more thoroughly
Phase 2
Support thyroid responsiveness
The low Na/K ratio suggests impaired adrenal-thyroid signaling.
Interventions may include:
- Adequate sodium and potassium. Dietary potassium intake should be increased to 4500mg daily.
- Improved carbohydrate intake (carbs with each meal), likely up to 200g carbs daily if tolerated.
- Sleep optimization
- Correction of chronic inflammation
Expected Outcome
Within 4-6 months:
- Ceruloplasmin rises
- Serum iron rises
- Ferritin often decreases
- Hair iron begins declining
Symptoms frequently improve despite giving no supplemental iron.
👉 Continue reading in Substack
With warmth and wellness,
Lauren Keller
APRN, Certified Nurse Midwife
Responses